We are live on
!
Find out more
AC
Almitas Capital Portfolio holdings
AUM
$443M
1-Year Est. Return
42.36%
This Fund
S&P 500
This Quarter
Est. Return
-6.08%
1 Year Est. Return
+42.36%
3 Year Est. Return
+85.86%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$301M
AUM Growth
-$155M
(-34%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-43.37%
Top 10 Holdings %
Top 10 Hldgs %
67.47%
Holding
106
New
15
Increased
35
Reduced
17
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$3.21M |
| 2 |
Cannae Holdings
CNNE
|
+$2.71M |
| 3 |
Madison Square Garden
MSGS
|
+$2.05M |
| 4 |
DMF
BNY Mellon Municipal Income
DMF
|
+$1.98M |
| 5 |
PCQ
Pimco California Municipal Income Fund
PCQ
|
+$1.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FETH
Fidelity Ethereum Fund
FETH
|
+$31.4M |
| 2 |
OBDE
Blue Owl Capital Corporation III
OBDE
|
+$27.2M |
| 3 |
BlackRock Health Sciences Trust II
BMEZ
|
+$17.8M |
| 4 |
ETH
Grayscale Ethereum Staking Mini ETF Shares
ETH
|
+$16.2M |
| 5 |
TPZ
Tortoise Electrification Infrastructure ETF
TPZ
|
+$11.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.11% |
| 2 | Real Estate | 2.48% |
| 3 | Financials | 1.82% |
| 4 | Consumer Discretionary | 0.87% |
| 5 | Communication Services | 0.64% |
Similar funds
HBT
EFMC
BFA
CP
CMP
PLU
TC
TAS
Almitas Capital's Q1 2025 Portfolio in Review
As of Q1 2025, Almitas Capital held 106 positions worth $301M, down 34% from $456M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Almitas Capital withdrew a net $131M in Q1 2025, closing 25 positions and reducing 17 holdings. Its most notable exit was Fidelity Ethereum Fund, an estimated $31.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, up from 7.8% a quarter earlier, followed by Real Estate and Financials.
Against the trend, Almitas Capital opened a new position in Cannae Holdings worth $2.63M.
- Almitas Capital's largest Q1 2025 buy was Cannae Holdings: 143,651 shares worth $2.63M.
- Almitas Capital added most to Nektar Therapeutics in Q1 2025, an estimated $3.21M increase.
- Almitas Capital's biggest Q1 2025 reduction was BlackRock Health Sciences Trust II, cutting an estimated $17.8M.
- Almitas Capital fully exited Fidelity Ethereum Fund in Q1 2025, selling an estimated $31.4M.
- Almitas Capital's ten largest holdings make up 67% of its $301M portfolio in Q1 2025.
- Almitas Capital opened 15 new positions and closed 25 in Q1 2025.
- Almitas Capital's portfolio value fell 34% quarter-over-quarter to $301M.
Based on Almitas Capital's 13F filing for Q1 2025, filed 15 May 2025.